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Abstract 
Bovine cultured adrenal medullary cells (4 x 106) contained 4266.5 f 370.0 fmol of immunoreactive adrenomedullin and 373.4 + 32.6 mnol of 
catecholamines. Nicotinic (but not muscarinic) receptors mediated the Ca2+-dependent co-secretion of adrenomedullin and catecholamines, with the 
molar ratio of adrenomedullinkatecholamines s creted into the medium being equal to the ratio stored in the cells. The concentration-response curve 
of carbachol for adrenomedullin secretion (ECSo 42 PM) was similar to that for catecholamine secretion (ECSo 63 PM). Reverse phase HPLC analysis 
showed that immunoreactive adrenomedullins in the cells and secreted into the medium were both eluted exclusively at the position almost identical 
to synthetic human adrenomedullin[l-52]NH,. 
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1. Introduction 
Adrenomedullin (AM) is a novel hypotensive peptide 
recently discovered in human pheochromocytoma [ 11, by 
using an assay system which monitored its activity to 
elevate CAMP in rat platelets [l]. AM, consisting of 52 
amino acids, has one intramolecular disulfide bond and 
shows a 17% of amino acid sequence homology with 
calcitonin gene-related peptides (CGRP-I, II) that also 
raise CAMP levels to cause vasodilatation. In anesthe- 
tized rats, the intravenous bolus administration of AM 
produced a rapid, marked and long-lasting decrease in 
blood pressure [1,2]. In the perfused rat mesenteric vas- 
culature, AM produced a concentration-dependent vaso- 
dilatation, and it was inhibited by CGRPsm3’, an antago- 
nist for CGRP receptor, but not by antagonists for mus- 
carinic and /I-adrenergic receptors [3]. 
Adrenal medullary cells (embryologically derived 
from neural crest) share common properties with 
adrenergic neurons. The functions of adrenal medulla 
are under the control of acetylcholine released from pre- 
ganglionic splanchnic nerves. Tissue concentrations of 
ir-AM in human pheochromocytoma nd adrenal me- 
dulla are three to four orders of magnitude higher than 
those in kidney and lung [l]. The ir-AM was also de- 
tected in plasma, suggesting that an endogenous AM in 
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Abbreviations: ir-AM, immunoreactive adrenomedullin; CGRP, calci- 
tonin gene-related peptide; ANP, atria1 natriuretic peptide; TFA, tri- 
fluoroacetic acid; EDTA, ethylenediaminetetraacetic acid; HPLC, 
high-performance liquid chromatography; KRP, Krebs-Ringer phos- 
phate; EC,,, half-maximal effective concentration. 
circulation may be involved in the regulation of blood 
pressure. However, it has not been documented that the 
secretion of AM is modulated by neuro/humoral-trans- 
mitter(s). In addition, the origin(s) of plasma ir-AM and 
the molecular form(s) of ir-AM secreted into circulation 
are unknown. We now provide the first evidence that 
AM[l-52]NH, is secreted along with catecholamines by 
a Ca”-dependent exocytosis following the stimulation of 
nicotinic receptors in bovine cultured adrenal medullary 
cells. 
2. Materials and methods 
2.1. Primary culture 
Bovine adrenal medullary cells were isolated and cultured (4 x lo6 
cells/dish, Falcon 35 mm) in Eagle’s minimum essential medium con- 
taining 10% calf serum and antibiotics [4]. Oxygenated KrebsRinger 
phosphate (KRP) buffer (mM) (NaCl 154, KC1 5.6, MgSO, 1.1, CaCl, 
2.2, NaH,PO, 0.85, Na,HPO, 2.15, glucose 10; and 0.5% bovine serum 
albumin, pH 7.4) was used throughout. 
2.2. Secretion of AM and catecholamines 
Secretion of AM and catecholamines was measured by incubating the 
cells at 37°C in 1.0 ml of KRP buffer with or without test compounds 
[4]. The reaction was terminated by transferring the medium to an assay 
tube that contained EDTA (3 mM) and aprotinin (500 KIU/ml) to 
inactivate proteases. 
2.3. Measurement of AM 
AM secreted into the medium was measured in duplicate by radioim- 
munoassay (RIA) [5]. The incubation buffer for RIA was 0.05 M 
sodium phosphate buffer (PH 7.4), containing 0.5% bovine serum albu- 
min, 0.5% Triton X-100,0.08 M NaCl, 0.025 M EDTA-2Na and 0.05% 
NaN,. An aliquot (lOa@) of the secretion medium was reacted at 4°C 
for 24 h with 50 ~1 of rabbit antiserum (dilution 1: 182,250) raised 
against human AM[40_52]NH, and 50 ~1 of ‘ZSI-labelled human 
AM[40-52]NH2 (18,000 cpm) prepared by Bolton-Hunter method. The 
antiserum specifically recognized the C-terminal region of AM, and did 
not exhibit cross-reactivity with CGRP-I, II and neuropeptide Y 151. 
The RIA has 100% cross-reactivity with bovine AM[45-52]NH, de- 
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duced from cDNA analysis of bovine AM (manuscript in preparation), 
whose amino acid sequence is identical to human AM[45-52]NH,. Free 
and bound tracers were separated by polyethyleneglycol method, and 
the radioactivity in the pellet was counted in a y-counter (ARC-600, 
Aloka). 
To measure AM in cells, cells were detached, boiled in 1 M acetic acid 
(to inactivate proteases). homogenized and centrifuged at 24,000 x g for 
30 min. The resultant supernatant was applied to a Sep-Pak C-18 
cartridge (Waters, Inc., MA, USA) pre-equilibrated with 0.5 M acetic 
acid. After washing the column with 0.5 M acetic acid, the adsorbed 
materials were eluted with 60% acetonitrile containing 0.1% tri- 
fluoroacetic acid (TFA), evaporated and finally dissolved in RIA buffer 
to submit RIA. 
The ir-AMs in cell extract and secretion medium were analyzed by 
reverse phase HPLC, using a column of TSK ODS 120A (4.6 x 150 mm, 
Tosoh) [1,5]. 
2.4. Measurement of catecholamines (epinephrine plus norepinephrine) 
Catecholamines were adsorbed to alumina, eluted with 0.2 N per- 
chloric acid and measured by HPLC [6]. Recovery of the internal 
standard 3,4-dihydroxybenzylamine was 87.5 f 1.7% (n = 10). 
2.5. Chemicals 
Eagle’s minimum essential medium, Nissui Seiyaku; calf serum and 
EDTA, Nacalai Tesque; atropine, carbachol, hexamethonium and 
muscarine, Sigma; nicotine, Tokyo Kasei; aprotinin, Bayer AC. 
Human synthetic AM was prepared by solid phase methods in Peptide 
Institute, Inc., Osaka, Japan. 
2.6. Statistical analysis 
All values were expressed as mean f S.E.M. 
3. Results 
3.1. Time courses of carbachol-induced secretion of AA4 
and catecholamines 
Carbachol evoked a rapid and transient secretion of 
AM and catecholamines, both of which occurred within 
1 min and then leveled off, whereas the basal secretion 
of AM and catecholamines remaind at low levels (Fig. 
1). Over a period of 5 min, carbachol(300 PM)-induced 
secretion of AM and catecholamines were 710.8 f 30.4 
fmol (n = 5) and 62.28 f 9.80 nmol (n = 6) from 4 x lo6 
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cells, corresponding to 16.7 and 16.7% of the total cellu- 
lar AM and catecholamines, respectively. 
3.2. Concentration-response curves of carbachol for 
secretion of AM and catecholamines 
Carbachol, at the same concentration range, increased 
the secretion of both AM and catecholamines in a con- 
centration-dependent manner, and they attained their 
maximal level at 300 ,uM carbachol (Fig. 2). The EC,, 
values of carbachol for AM and catecholamine secretion 
were 42 and 63 ,uM, respectively. 
3.3. Molar ratio of ir-AMand catecholamines in secretion 
medium and adrenal medullary cells 
Bovine cultured adrenal medullary cells (4 x 106) con- 
tained 4266.5 + 370.0 fmol of ir-AM and 373.4 f 32.6 
nmol of catecholamines, the molar ratio of ir-AM/cate- 
cholamines being 11.41 f 1.14 x low6 (n = 5). The molar 
ratios of ir-AM/catecholamines ecreted into the medium 
during a 5 min incubation period were 11.90 + 0.40 x 
10m6, 11.87 f 0.27 x 10e6, 11.77 f 0.74 x low6 and 10.33 
+ 0.34 x 10m6 (n = 4) at 50, 100, 300 and 1000 FM of 
carbachol, respectively. 
3.4. Effect of extracellular Cd’ removal 
In adrenal medulla, an influx of Ca*’ via voltage-de- 
pendent Ca2’ channels is indispensable for the exocytotic 
secretion of catecholamines [4]. Over a 5 min incubation 
period, the secretion of AM and catecholamines induced 
by carbachol (300 PM) were abolished in the Ca*+-free 
medium, although the basal secretion of AM and cat- 
echolamines were not significantly altered (data not 
given). 
3.5. Effects of nicotinic and muscarinic agents 
Carbachol-induced secretion of AM was inhibited by 
hexamethonium (1 mM), an antagonist for nicotinic re- 
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Fig. 1. Time courses of carbachol-induced secretion of ir-AM (A) and catecholamines (B) from cultured bovine adrenal medullary cells. The cells 
were incubated in 1.0 ml of KRP buffer at 37°C in the absence (0) or presence (0) of carbachol (300 PM). 
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Fig. 2. Concentration-response curves of carbachol for the secretion of ir-AM (A) and catecholamines (B). Cultured cells were stimulated at 37°C 
for 5 min with various concentrations of carbachol (CCh). Values obtained at 37°C without carbachol were subtracted. Each point represents the 
mean f S.E.M. (n = 4). 
ceptors, but not by atropine (1 PM), an antagonist for 
muscarinic receptors (Fig. 3). Nicotine (100 ,uM) induced 
AM secretion to the same extent as that caused by car- 
bachol (300 PM), whereas muscarine (100 PM) did not 
increase AM secretion. 
3.6. Analysis of ir-AM in the secretion medium and cell 
extract of adrenal medulla 
Molecular forms of ir-AM in the secretion medium 
and acid extract of adrenal medullary cells were charac- 
terized by reverse phase HPLC, using a column of TSK 
ODS 120A coupled with RIA for AM. Molecular forms 
of ir-AM in both preparations were composed of the 
major peak and several minor peaks, as shown in Fig. 
4. The major peak in the secretion medium appeared at 
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Fig. 3. Effects of cholinergic agents on ir-AM secretion. The cells were 
incubated at 37°C for 5 min with or without the indicated drugs. 
Carbachol (CCh), 3OOyM; hexamethonium (C,), 1 mM; atropine (Atr), 
1 ,uM; nicotine, 100 PM and muscarine, 100 PM. Means f S.E.M. 
(n = 4). 
an elution position almost identical to that of cell extract, 
and they corresponded to the elution position of syn- 
thetic human AM[ l-52]NH2. 
4. Discussion 
In the present study, carbachol caused a rapid and 
transient secretion of ir-AM in a time course similar to 
that of catecholamine secretion. The concentration-re- 
sponse curve of carbachol for ir-AM secretion was also 
indistinguishable from that for catecholamine secretion. 
Carbachol-induced secretion of ir-AM was abolished by 
hexamethonium, but not by atropine. Nicotine evoked 
ir-AM secretion, while muscarine had no effect. These 
results indicate that nicotinic (but not muscarinic) recep- 
tors mediate the secretion of ir-AM, in accordance with 
the secretion of catecholamines [4]. 
In adrenal medulla, catecholamines are stored exclu- 
sively in chromaffin granules and secreted by a Ca”- 
dependent exocytosis [7]. Chromaffin granules have been 
documented to contain a number of biologically active 
peptides [8,9], such as enkephalins [lO-121, neuropeptide 
Y [13,14], and atria1 natriuretic peptide (ANP)-related 
peptides [l&16], which are cosecreted along with cat- 
echolamines by a Ca*‘-dependent exocytosis. 
In the present study, carbachol failed to stimulate the 
secretion of ir-AM as well as catecholamines in a Ca2’- 
free medium. The molar ration of ir-AM/catecholamines 
secreted into the medium was quite similar to the ratio 
stored in adrenal medullary cells. Our previous experi- 
ments documented that the mature form of AM in adre- 
nal medulla is produced by the processing from prepro 
AM via pro AM, and the major ir-AM in human adrenal 
medulla is mature AM which consists of 52 amino acids 
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Fig. 4. Reverse phase HPLC analysis of ir-AM in the secretion medium 
and in cell extract of adrenal medulla. Sample: (a) secretion medium, 
(b) cell extract. Column: TSK ODS 120A (4.6 x 150 mm, Tosoh). Flow 
rate: 1 .O ml/min. Solvent system: (A) H20/CH$N/10% TFA, 90 : 10: 1 
(v/v); (B) H20/CHgCN/10% TFA, 40 : 60: 1 (v/v). Linear gradient from 
(A) to (B) for 60 min. The arrow indicates the elution position of 
synthetic human AM[l-52]NH2. Although CGRPs were also eluted at 
a similar position, they did not cross-react with the antiserum raised 
against human AM[40-52]NH2 [5]. 
[5]. In the present study, reverse-phase HPLC analysis 
showed that ir-AM stored in the cells and secreted into 
the medium were both eluted at the position almost iden- 
tical to human AM[ l-52]NHz. These results suggest hat 
the processing pathway of bovine AM is quite similar to 
that of human AM, and AM is cosecreted with catechol- 
amines in the same molecular form as it exists in chro- 
maffin granules. 
Although it is still obscure to what extent AM secreted 
from adrenal medulla contributes to its plasma level, and 
the physiological significance of endogenous AM is not 
precisely known, a large amount of AM secreted from 
adrenal medulla seems to be involved in the modulation 
of vascular tone. In addition, enkephalin [17] and neu- 
ropeptide Y [18] secreted from adrenal medulla were 
reported to inhibit nicotinic receptor-mediated catechol- 
amine secretion. Our previous study in bovine cultured 
adrenal medullary cells also documented that ANP-re- 
lated peptides phosphorylated and activated tyrosine hy- 
droxylase, the enzyme catalyzing the rate-limiting step in 
the biosynthesis of catecholamines, in a cGMP-depend- 
ent process(es) [19]. It is intriguing to conjecture that 
AM, the potent vasorelaxing peptide, cosecreted with 
catecholamines, would modulate the secretion and/or 
synthesis of catecholamines, although the existence of 
the AM receptor in adrenal medulla, by itself, is still 
putative. 
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